Description
Irinotecan for Infusions
Generic Name: Irinotecan
Strength: 20 mg/ml.
Presentation: 25 ml. / 500 mg. vial
Description
Irinotecan is a chemotherapy medication used for the treatment of various types of cancer. It is administered through intravenous infusion and comes in a concentration of 20 mg/ml. Each vial contains 25 ml. of solution, equivalent to 500 mg. of irinotecan.
Indications
Irinotecan is indicated for the treatment of:
- Colorectal cancer
- Lung cancer
- Pancreatic cancer
- Gastric cancer
- Other solid tumors
How It Works
Irinotecan works by inhibiting the enzyme topoisomerase I, which is involved in DNA replication. By interfering with this process, irinotecan prevents cancer cells from dividing and multiplying, ultimately leading to cell death.
Administration
Irinotecan is administered as an intravenous infusion over a specified period of time, usually in a clinical setting such as a hospital or infusion center. The dosage and infusion schedule will be determined by a healthcare provider based on the patient’s condition and response to treatment.
Side Effects
Like all chemotherapy medications, irinotecan can cause side effects. Common side effects may include:
- Nausea and vomiting
- Diarrhea
- Fatigue
- Low blood cell counts
- Hair loss
- Mouth sores
It is important for patients to report any side effects to their healthcare provider for proper management.
Precautions
Before receiving irinotecan, patients should inform their healthcare provider about any medical conditions they have, including:
- Liver or kidney problems
- Previous chemotherapy or radiation therapy
- Allergies to medications
- Pregnancy or breastfeeding
These factors may affect the safety and effectiveness of irinotecan treatment.
Storage
Irinotecan vials should be stored according to the manufacturer’s instructions, typically at room temperature away from light and moisture. Proper storage helps maintain the stability and integrity of the medication for use.
Conclusion
Irinotecan for infusions is a potent chemotherapy medication used in the treatment of various types of cancer. With its mechanism of action targeting cancer cells at the DNA level, irinotecan plays a crucial role in the management of solid tumors. Patients receiving irinotecan should be closely monitored for side effects and provided with supportive care to optimize treatment outcomes.
